利用细胞外容积分数评估慢性肝病进展中肝段纤维化的差异
本研究纳入218例慢性肝病患者和85例无慢性肝病对照,行双能CT肝脏5分钟平衡期扫描并计算肝细胞外容积分数(fECV)。结果显示在ALBI 2级中,内侧段和前段fECV显著大于其他肝段(p < 0.001);外侧段和后段fECV随ALBI分级升高显著增加(p < 0.001),而内侧段和前段fECV在ALBI 2级前随分级升高显著增加(p < 0.001),但ALBI 2级与3级间无显著差异。结论提示慢性肝病进展中纤维化先累及内侧段和前段,随后累及其他肝段。
要点
- 双能CT 5分钟平衡期计算fECV可评估慢性肝病肝段纤维化差异。
- ALBI 2级中内侧段和前段fECV显著大于其他肝段(p < 0.001)。
- 外侧段和后段fECV随ALBI分级升高显著增加(p < 0.001)。
核心结论
- 慢性肝病进展过程中,纤维化先在内侧段和前段进展,随后累及其他肝段。
研究设计与样本
- 研究纳入218例慢性肝病患者(92男、126女,平均年龄67.8 ± 11.7岁)和85例无慢性肝病对照(44男、41女,平均年龄62.8 ± 13.7岁),均行肝脏双能CT检查(5分钟平衡期图像),测量外侧段、内侧段、前段、后段及主动脉碘密度并计算fECV,按ALBI分级进行统计分析。
诊断标准与关键数值
- 在对照组及ALBI 1级和3级中,各肝段间fECV无显著差异;在ALBI 2级中,内侧段和前段fECV显著大于其他肝段(p < 0.001)。外侧段和后段fECV随ALBI分级升高显著增加(p < 0.001);内侧段和前段fECV随ALBI分级升高显著增加至2级(p < 0.001),但ALBI 2级与3级间无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the segmental difference of liver fibrosis during the progression of chronic liver disease (CLD) using hepatic extracellular volume fractions (fECVs) obtained by dual-energy CT.
METHODS: A total of 218 patients (92 men and 126 women; mean age, 67.8 ± 11.7 years) with CLD and 85 patients (44 men and 41 women; mean age, 62.8 ± 13.7 years) without CLD as a control underwent dual-energy computed tomography (CT) of the liver (5-min equilibrium phase images). The iodine densities of the lateral, medial, anterior, and posterior segments and the aorta were measured, and fECVs were calculated. Comparisons of the fECV of each segment and for each albumin-bilirubin (ALBI) grade were then statistically analyzed.
RESULTS: In the control group and ALBI grades 1 and 3, no significant difference in fECV was found between each segment, whereas in ALBI grade 2, the fECVs were significantly larger in the medial and anterior than in the other segments (p < 0.001). The fECVs of the lateral and posterior segments significantly increased with higher ALBI grade (p < 0.001). The fECVs of the medial and anterior segments were significantly increased with higher ALBI grade, up to grade 2 (p < 0.001), but no significant difference was found between ALBI grades 2 and 3.
CONCLUSION: During the progression of CLD, fibrosis antecedently progressed in the medial and anterior segments, followed by the other liver segments.
引用
- Ozaki, Ishida, Ohtani, et al. Assessing the progression of segmental fibrosis in chronic liver disease using extracellular volume fractions. Eur J Radiol. 2021. PMID: 34808581. doi:10.1016/j.ejrad.2021.110033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。